Skip to main content

Lung Cancer HELPLine 833-797-5800

LUNGevity.org

Navigating EGFR

Lung Cancer HELPLine 833-797-5800

Visit our other Patient Gateways  

Main navigation

  • About EGFR-Positive Lung Cancer
  • Learn About Clinical Trials
  • Find Your Community
  • News and Events
  • Library

Main navigation

  • EGFR
    • About EGFR-Positive Lung Cancer
    • Learn About Clinical Trials
    • Find Your Community
    • News and Events
    • Library

EGFR

Video Library

  • Title slide

    Article

    July 07, 2025

    New Treatment for Patients with Metastatic NSCLC with EGFR Exon 20 Insertion Mutations

    On July 2, 2025, the US Food and Drug Administration (FDA) announced the accelerated approval of sunvozertinib (Zegfrovy®) to treat patients with locally advanced or metastatic non...
    READ MORE about New Treatment for Patients with Metastatic NSCLC with EGFR Exon 20 Insertion Mutations ›
  • Title slide

    Article

    July 03, 2025

    2025 ASCO: Highlights of Lung Cancer Research

    The annual meeting of the American Society of Clinical Oncology (ASCO) once again brought together nearly 50,000 members of the oncology community. From May 30 – June 2...
    READ MORE about 2025 ASCO: Highlights of Lung Cancer Research ›
  • Title slide

    Video

    July 01, 2025

    Understanding DTPCs: A Path to Ending Drug Resistance in Lung Cancer

    When a person is treated for advanced-stage lung cancer, tumors will often shrink, and their symptoms may subside. An effective treatment will kill many tumor cells, but there are...
    READ MORE about Understanding DTPCs: A Path to Ending Drug Resistance in Lung Cancer ›
  • Drug approval graphic

    Article

    June 24, 2025

    New ADC Treatment Approved for Advanced EGFR+ NSCLC

    On June 23, 2025, the US Food and Drug Administration (FDA) announced the approval of datopotamab deruxtecan-dlnk (Datroway® or Dato-DXd) to treat patients with locally advanced or...
    READ MORE about New ADC Treatment Approved for Advanced EGFR+ NSCLC ›
  • Title slide

    Article

    June 21, 2025

    Sharing Experiences With EGFR Lung Cancer: A Tool Shaped by Patients and Caregivers

    Why did we build a tool to visualize data collected from patients and caregivers? Community members provide data but too often never see how their data was used. Research data is...
    READ MORE about Sharing Experiences With EGFR Lung Cancer: A Tool Shaped by Patients and Caregivers ›
  • Title slide

    Article

    June 16, 2025

    Surviving LMD: Michelle Never Settled for “No”

    Michelle knew what was wrong. She knew the headaches, regular vomiting, ear popping, and “whooshing” sounds in her head were all signs of leptomeningeal disease (LMD). The issue...
    READ MORE about Surviving LMD: Michelle Never Settled for “No” ›
  • HOPE Summit logo

    Video

    May 18, 2025

    Watch HOPE Summit Videos

    HOPE Summit 2025 was filled with messages of hope, meeting new and hugging old friends, and of course the inspirational and informative sessions that help people live well with...
    READ MORE about Watch HOPE Summit Videos ›
  • Titile banner

    Video

    April 16, 2025

    What Are Antibody-Drug Conjugates and How Do They Treat Lung Cancer?

    Historically, approaches to treating lung cancer included surgery, radiation, and chemotherapy. The past decade ushered in a new era of treatments with targeted therapy and...
    READ MORE about What Are Antibody-Drug Conjugates and How Do They Treat Lung Cancer? ›
  • Title graphic

    Video

    April 07, 2025

    Integrative Oncology and Lung Cancer: Adding Complementary Therapy

    What Is Integrative Oncology? Integrative oncology is the use of complementary therapies alongside conventional lung cancer treatments like chemotherapy, targeted therapy, surgery...
    READ MORE about Integrative Oncology and Lung Cancer: Adding Complementary Therapy ›
  • Title slide

    Video

    March 27, 2025

    What Should Patients Know About Lung Cancer Surgery?

    Surgery is a treatment option for early-stage lung cancer that involves removing all or part of a lung to treat a cancerous tumor. It is primarily an option for people with non...
    READ MORE about What Should Patients Know About Lung Cancer Surgery? ›
  • Title slide

    Video

    March 20, 2025

    Conversations that Count: Transforming Lung Cancer Care Through Insight and Innovation

    The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from top experts revolutionizing lung cancer...
    READ MORE about Conversations that Count: Transforming Lung Cancer Care Through Insight and Innovation ›
  • Title slide

    Video

    March 19, 2025

    How Do We Treat Early-Stage NSCLC in 2025?

    Roughly 20% of lung cancer is diagnosed as early-stage disease, and researchers have been working to improve treatment options for these patients—with significant success. Last...
    READ MORE about How Do We Treat Early-Stage NSCLC in 2025? ›

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

You are about to leave the Patient Gateway

You’re one click away from learning about one of our most valued sponsors. Read about how they’re making a difference in patients’ lives.

ProceedCancel

SHARE

The Patient Gateways are a project of LUNGevity Foundation, an organization transforming how people are diagnosed and live with lung cancer. Learn more here.

Privacy policy | Contact us

 

This website is not intended to, and does not, provide medical advice, professional diagnosis, opinion, treatment, or services. Medical information provided on this site is for informational and educational purposes only. After reading content from this website, you are encouraged to review the information carefully with your physician.

 

Copyright © 2025 LUNGevity Foundation. All rights reserved.